• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性放疗在肺癌治疗中的作用。

The role of curative radiotherapy in the treatment of lung cancer.

作者信息

Coy P, Kennelly G M

出版信息

Cancer. 1980 Feb 15;45(4):698-702. doi: 10.1002/1097-0142(19800215)45:4<698::aid-cncr2820450414>3.0.co;2-8.

DOI:10.1002/1097-0142(19800215)45:4<698::aid-cncr2820450414>3.0.co;2-8
PMID:6244073
Abstract

From 1963-1974, 141 patients with lung cancer were treated with curative intent in the A. Maxwell Evans Clinic in Vancouver. The clinical presentation, age and sex distribution, histology, and reasons for surgery not being carried out are examined. The results of this treatment are presented. An attempt has been made to isolate a group of patients who have a better prognosis so that treatment selection can be improved. Hemoptysis, cough, dyspnea, and incidental finding on routine chest x-ray were the most common manner of presentation. Thirty-four percent of the patients were over 70 years of age and 13% were women. The crude overall three- and five-year survival rates were 18 and 10% (19 and 9% in the men, 17 and 14% in the women). Patients presenting with dyspnea had a better survival than those presenting with cough and hemoptysis. Patients with lesions less than 3 cm in diameter had a 28% three-year survival, compared with 14% for lesions greater than 5 cm in diameter. The three- and five-year survival rates in patients over 70 years of age were 23 and 17% respectively. The response to treatment and the survival was better in the patients with squamous cell carcinoma. Twenty-two percent were alive at three years and 12% at five years as compared with 9 and 5% for other histologies. Fifty-four percent of the 35 patients with a complete response and with squamous cell carcinoma were alive at three years, compared with only 8% of the 12 patients with other histologies who showed a complete response.

摘要

1963年至1974年期间,温哥华的A. 麦克斯韦·埃文斯诊所对141例肺癌患者进行了根治性治疗。本文对患者的临床表现、年龄和性别分布、组织学类型以及未进行手术的原因进行了研究,并展示了治疗结果。我们试图找出一组预后较好的患者,以便改进治疗方案的选择。咯血、咳嗽、呼吸困难以及常规胸部X光检查时偶然发现是最常见的临床表现方式。34%的患者年龄超过70岁,13%为女性。总的三年和五年粗生存率分别为18%和10%(男性为19%和9%,女性为17%和14%)。以呼吸困难为表现的患者生存率高于以咳嗽和咯血为表现的患者。直径小于3厘米的病灶患者三年生存率为28%,而直径大于5厘米的病灶患者三年生存率为14%。70岁以上患者的三年和五年生存率分别为23%和17%。鳞状细胞癌患者对治疗的反应和生存率更好。三年时22%存活,五年时12%存活,而其他组织学类型的患者三年和五年生存率分别为9%和5%。35例完全缓解的鳞状细胞癌患者中,54%在三年时存活,而12例其他组织学类型且完全缓解的患者中只有8%在三年时存活。

相似文献

1
The role of curative radiotherapy in the treatment of lung cancer.根治性放疗在肺癌治疗中的作用。
Cancer. 1980 Feb 15;45(4):698-702. doi: 10.1002/1097-0142(19800215)45:4<698::aid-cncr2820450414>3.0.co;2-8.
2
Telecobalt therapy for malignant lung tumours.恶性肺肿瘤的远距离钴治疗
Acta Radiol Ther Phys Biol. 1976 Oct;15(5):394-400. doi: 10.3109/02841867609131773.
3
Radiotherapy for suspected lung cancer not proved by tissue diagnosis.针对未经组织诊断证实的疑似肺癌进行的放射治疗。
Chest. 1973 Oct;64(4):476-9. doi: 10.1378/chest.64.4.476.
4
High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.高剂量率支气管内近距离放射治疗在肺癌治疗中的应用:158例患者的疗效与毒性评估
Lung Cancer. 2008 Dec;62(3):326-33. doi: 10.1016/j.lungcan.2008.03.018. Epub 2008 May 14.
5
[High-dose endobronchial brachytherapy in malignant tumors of the lung].[高剂量支气管内近距离放射治疗在肺癌恶性肿瘤中的应用]
Arch Bronconeumol. 1997 Jun;33(6):278-83.
6
Prophylactic cranial irradiation in patients with inoperable carcinoma of the lung: preliminary report of a cooperative trial.
Cancer. 1978 Sep;42(3):1135-40. doi: 10.1002/1097-0142(197809)42:3<1135::aid-cncr2820420316>3.0.co;2-n.
7
The role of radiotherapy in squamous, large cell, and adenocarcinoma of the lung.放射治疗在肺鳞状细胞癌、大细胞癌和腺癌中的作用。
Semin Oncol. 1983 Mar;10(1):81-94.
8
Results of a limited resection for compromised or poor-risk patients with clinical stage I non-small cell carcinoma of the lung.
J Am Coll Surg. 1995 Jul;181(1):33-7.
9
Significance of postoperative irradiation for stage III lung cancer.Ⅲ期肺癌术后放疗的意义
Radiat Med. 1984 Apr-Jun;2(2):143-7.
10
The relative radioresponsiveness of small cell lung cancer.小细胞肺癌的相对放射反应性。
Radiat Med. 1988 Nov-Dec;6(6):282-4.

引用本文的文献

1
Recent Trends of Medical Expenses Associated with Radiation Therapy in Korea Based on HIRA Big Data.基于 HIRA 大数据的韩国放射治疗相关医疗费用的最新趋势。
Cancer Res Treat. 2023 Jul;55(3):758-765. doi: 10.4143/crt.2022.389. Epub 2023 Jan 30.
2
Safety and efficacy of 10-fraction hypofractionated radiation therapy for non-small cell lung cancer.10次分割的大分割放射治疗非小细胞肺癌的安全性和疗效
Radiat Oncol J. 2021 Sep;39(3):202-209. doi: 10.3857/roj.2021.00416. Epub 2021 Sep 9.
3
Inoperable early-stage primary and early recurrent non-small cell lung cancer: outcomes of a mono-institutional experience using a moderate hypofractionated schedule.
无法手术的早期原发性和早期复发性非小细胞肺癌:采用中度亚分割方案的单机构经验的结果。
Radiol Med. 2019 Jan;124(1):58-64. doi: 10.1007/s11547-018-0934-z. Epub 2018 Sep 3.
4
New era of radiotherapy: an update in radiation-induced lung disease.新时代的放射治疗:放射性肺损伤的最新进展。
Clin Radiol. 2013 Jun;68(6):e275-90. doi: 10.1016/j.crad.2013.01.013. Epub 2013 Mar 6.
5
Dosimetric verification using monte carlo calculations for tissue heterogeneity-corrected conformal treatment plans following RTOG 0813 dosimetric criteria for lung cancer stereotactic body radiotherapy.使用蒙特卡罗计算对肺癌立体定向体部放射治疗 RTOG 0813 剂量学标准下组织不均匀性校正的适形治疗计划进行剂量验证。
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):508-13. doi: 10.1016/j.ijrobp.2011.12.005. Epub 2012 Feb 24.
6
An orthotopic lung tumor model for image-guided microirradiation in rats.用于大鼠图像引导微照射的原位肺肿瘤模型。
Radiat Res. 2010 Jul;174(1):62-71. doi: 10.1667/RR2157.1.
7
Effectiveness of radiation therapy for elderly patients with unresected stage I and II non-small cell lung cancer.放疗治疗未切除的 I 期和 II 期老年非小细胞肺癌患者的疗效。
Am J Respir Crit Care Med. 2010 Feb 1;181(3):264-9. doi: 10.1164/rccm.200907-1064OC. Epub 2009 Nov 5.
8
A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy.一项对接受低分割立体定向体部放射治疗的无法手术的 I 期非小细胞肺癌患者进行的 18F-氟脱氧葡萄糖正电子发射断层扫描序贯试验。
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):789-95. doi: 10.1016/j.ijrobp.2009.02.051. Epub 2009 May 25.
9
Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer.RTOG 0236中不均匀性校正的剂量学评估:不可手术的I-II期非小细胞肺癌的立体定向体部放疗
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1235-42. doi: 10.1016/j.ijrobp.2008.11.019.
10
[Lung cancer--hopelessness in inoperability? A 10-year follow-up].[肺癌——无法手术就绝望吗?一项10年随访研究]
Strahlenther Onkol. 1997 Jul;173(7):352-61. doi: 10.1007/BF03038238.